BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8874389)

  • 1. Aberrant expression of a hemidesmosomal protein, bullous pemphigoid antigen 2, in human squamous cell carcinoma.
    Yamada T; Endo R; Tsukagoshi K; Fujita S; Honda K; Kinoshita M; Hasebe T; Hirohashi S
    Lab Invest; 1996 Oct; 75(4):589-600. PubMed ID: 8874389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hemidesmosomal transmembrane collagenous molecule, the 180-kDa bullous pemphigoid antigen (BPA II), is phosphorylated with 12-O-tetradecanoylphorbol-13-acetate in a human squamous cell carcinoma cell line (DJM-1).
    Kitajima Y; Owada MK; Fujisawa Y; Seishima M; Yaoita H; Hirako Y; Owaribe K
    Epithelial Cell Biol; 1995; 4(2):70-5. PubMed ID: 8688920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin.
    Ishiko A; Shimizu H; Kikuchi A; Ebihara T; Hashimoto T; Nishikawa T
    J Clin Invest; 1993 Apr; 91(4):1608-15. PubMed ID: 7682575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cloning of canine bullous pemphigoid antigen 2 cDNA and immunomapping of NC16A domain by canine bullous pemphigoid autoantibodies.
    Xu L; O'Toole EA; Olivry T; Hernandez C; Peng J; Chen M; Chan LS
    Biochim Biophys Acta; 2000 Jan; 1500(1):97-107. PubMed ID: 10564722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of collagen XVII expression during transformation of oral epithelium to dysplasia and carcinoma.
    Parikka M; Kainulainen T; Tasanen K; Väänänen A; Bruckner-Tuderman L; Salo T
    J Histochem Cytochem; 2003 Jul; 51(7):921-9. PubMed ID: 12810842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen XVII/BP180 protein expression in squamous cell carcinoma of the skin detected with novel monoclonal antibodies in archived tissues using tissue microarrays and digital microscopy.
    Stelkovics E; Korom I; Marczinovits I; Molnar J; Rasky K; Raso E; Ficsor L; Molnar B; Kopper L; Krenacs T
    Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):433-41. PubMed ID: 18633319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phorbol ester- and calcium-induced reorganization of 180-kDa bullous pemphigoid antigen on the ventral surface of cultured human keratinocytes as studied by immunofluorescence and immunoelectron microscopy.
    Kitajima Y; Owaribe K; Nishizawa Y; Jokura Y; Yaoita H
    Exp Cell Res; 1992 Nov; 203(1):17-24. PubMed ID: 1426040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased mRNA expression of several basement membrane components in basal cell carcinoma.
    Chopra A; Maitra B; Korman NJ
    J Invest Dermatol; 1998 Jan; 110(1):52-6. PubMed ID: 9424087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic growth of squamous cell carcinomas is correlated with upregulation and redistribution of hemidesmosomal components.
    Herold-Mende C; Kartenbeck J; Tomakidi P; Bosch FX
    Cell Tissue Res; 2001 Dec; 306(3):399-408. PubMed ID: 11735040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bullous pemphigoid antigen localization suggests an intracellular association with hemidesmosomes.
    Westgate GE; Weaver AC; Couchman JR
    J Invest Dermatol; 1985 Mar; 84(3):218-24. PubMed ID: 2579167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic domain of the 180-kD bullous pemphigoid antigen, a hemidesmosomal component: molecular and cell biologic characterization.
    Hopkinson SB; Riddelle KS; Jones JC
    J Invest Dermatol; 1992 Sep; 99(3):264-70. PubMed ID: 1512461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 180-kD bullous pemphigoid antigen/type XVII collagen: tissue-specific expression and molecular interactions with keratin 18.
    Aho S; Uitto J
    J Cell Biochem; 1999 Mar; 72(3):356-67. PubMed ID: 10022517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and characterization of monoclonal antibodies against the intracellular domain of hemidesmosomal type XVII collagen.
    Olaru F; Mihai S; Petrescu I; Zillikens D; Sitaru C
    Hybridoma (Larchmt); 2006 Jun; 25(3):158-62. PubMed ID: 16796463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular cleavage of bullous pemphigoid antigen 180/type XVII collagen and its involvement in hemidesmosomal disassembly.
    Hirako Y; Yoshino K; Zillikens D; Owaribe K
    J Biochem; 2003 Feb; 133(2):197-206. PubMed ID: 12761182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2.
    Zone JJ; Taylor TB; Meyer LJ; Petersen MJ
    J Invest Dermatol; 1998 Mar; 110(3):207-10. PubMed ID: 9506436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 97 kDa linear IgA bullous dermatosis antigen localizes in the lamina lucida between the NC16A and carboxyl terminal domains of the 180 kDa bullous pemphigoid antigen.
    Ishiko A; Shimizu H; Masunaga T; Yancey KB; Giudice GJ; Zone JJ; Nishikawa T
    J Invest Dermatol; 1998 Jul; 111(1):93-6. PubMed ID: 9665393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct interaction between the intracellular domains of bullous pemphigoid antigen 2 (BP180) and beta 4 integrin, hemidesmosomal components of basal keratinocytes.
    Aho S; Uitto J
    Biochem Biophys Res Commun; 1998 Feb; 243(3):694-9. PubMed ID: 9500991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning of partial cDNA for mouse 180-kDa bullous pemphigoid antigen (BPAG2), a highly conserved collagenous protein of the cutaneous basement membrane zone.
    Li K; Guidice GJ; Tamai K; Do HC; Sawamura D; Diaz LA; Uitto J
    J Invest Dermatol; 1992 Sep; 99(3):258-63. PubMed ID: 1512460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies.
    Stanley JR; Tanaka T; Mueller S; Klaus-Kovtun V; Roop D
    J Clin Invest; 1988 Dec; 82(6):1864-70. PubMed ID: 2461961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A possible cell-biologic mechanism involved in blister formation of bullous pemphigoid: anti-180-kD BPA antibody is an initiator.
    Kitajima Y; Hirako Y; Owaribe K; Yaoita H
    Dermatology; 1994; 189 Suppl 1():46-9. PubMed ID: 8049562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.